Samrat Pharmachem standalone net profit rises 239.34% in the June 2024 quarter
Sales rise 40.61% to Rs 80.82 crore
Net profit of Samrat Pharmachem rose 239.34% to Rs 2.07 crore in the quarter ended June 2024 as against Rs 0.61 crore during the previous quarter ended June 2023. Sales rose 40.61% to Rs 80.82 crore in the quarter ended June 2024 as against Rs 57.48 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales80.8257.48 41 OPM %3.191.34 -PBDT2.980.91 227 PBT2.820.75 276 NP2.070.61 239Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 13 2024 | 6:10 PM IST